LENTIVECTOR

Welcome to the Brand page for “LENTIVECTOR”, which is offered here for Clinical medical reagents for use in gene therapy; [ pharmaceutical preparations for use in gene therapy; therapeutic compositions containing retroviral vector preparations and/or nucleic acid suitable for gene therapy; ] retroviral vector preparations for use in gene therapy [ ; pharmaceutical preparations containing a retroviral vector delivering genes to cells for use in the treatment of viral and bacterial infections, cancer, hiv and aids, neurodegenerative diseases, diseases of the eye, leukemia and bodily conditions associated with impaired immunosystems ];chemical compositions containing nucleic acids for use in the manufacture of pharmaceuticals and retroviral vector preparations;scientific and medical research and development; genetic engineering services, biotechnology services, research and development of new products in the field of biotechnology;.

Its status is currently believed to be active. Its class is unavailable. “LENTIVECTOR” is believed to be currently owned by “Oxford BioMedica plc”.